A new trial update was posted on September 11, 2026, for the study titled "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes." The trial, registered as NCT07415954, is a Phase 2 study. Its current status is listed as recruiting. The study is designed to compare different doses of NNC0662-0419 in people with type 2 diabetes. No results have been posted for this trial at this time. The trial record does not provide additional details on enrollment size, duration, or comparator arms beyond the dose comparison design stated in the title. This update reflects only the recruitment status and phase information available in the public trial registry entry. Readers should note that recruiting status means the trial is open for participant enrollment and has not yet reported outcomes. For general background on semaglutide, readers can consult the compound overview.
Phase 2 Trial of NNC0662-0419 Dosing in Type 2 Diabetes Begins Recruiting
See the full semaglutide overview
Source: https://clinicaltrials.gov/study/NCT07415954